Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a literature review and proposed guidelines

INTRODUCTION: For patients with locally advanced estrogen receptor or progesterone receptor-positive breast cancer, neoadjuvant endocrine therapy (NET) facilitates down-staging of the tumor and increased rates of breast-conserving surgery. However, NET remains under-utilized, and there are very limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Madigan, Lauren I., Dinh, Phuong, Graham, J. Dinny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370425/
https://www.ncbi.nlm.nih.gov/pubmed/32690069
http://dx.doi.org/10.1186/s13058-020-01314-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370425/
https://www.ncbi.nlm.nih.gov/pubmed/32690069
http://dx.doi.org/10.1186/s13058-020-01314-6

Ejemplares similares